Publicaciones en las que colabora con Piero Crespo (14)

2022

  1. The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function

    Oncogene, Vol. 41, Núm. 24, pp. 3341-3354

2020

  1. RAC1 induces nuclear alterations through the LINC complex to enhance melanoma invasiveness

    Molecular biology of the cell, Vol. 31, Núm. 25, pp. 2768-2778

2019

  1. Corrigendum to: Vav mediates Ras stimulation by direct activation of the GDP/GTP exchange factor Ras GRP1 (The EMBO Journal, (2003), 22, 13, (3326-3336), 10.1093/emboj/cdg316)

    EMBO Journal

2018

  1. Protein–Protein Interactions: Emerging Oncotargets in the RAS-ERK Pathway

    Trends in Cancer, Vol. 4, Núm. 9, pp. 616-633

  2. RAS GTPase-dependent pathways in developmental diseases: old guys, new lads, and current challenges

    Current Opinion in Cell Biology, Vol. 55, pp. 42-51

  3. RAS at the Golgi antagonizes malignant transformation through PTPRκ-mediated inhibition of ERK activation

    Nature Communications, Vol. 9, Núm. 1

2007

  1. Transcriptomal profiling of site-specific Ras signals

    Cellular Signalling, Vol. 19, Núm. 11, pp. 2264-2276

2003

  1. Vav mediates Ras stimulation by direct activation of the GDP/GTP exchange factor Ras GRP1

    EMBO Journal, Vol. 22, Núm. 13, pp. 3326-3336

2002

  1. Walking pathways at Heidelberg. Conference on oncogenes and growth control

    EMBO Reports

1999

  1. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins

    Oncogene, Vol. 18, Núm. 43, pp. 5860-5869

1998

  1. El oncogén "vav"

    Investigación y ciencia, Núm. 262, pp. 62-71

1997

  1. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation

    Oncogene, Vol. 15, Núm. 21, pp. 2511-2520

  2. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product

    Nature, Vol. 385, Núm. 6612, pp. 169-172

1996

  1. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav

    Oncogene, Vol. 13, Núm. 3, pp. 455-460